Healthcare Sales & Marketing Network News: Navidea Biopharmaceuticals

Searching News Database: Navidea Biopharmaceuticals

HSMN NewsFeed - 16 Dec 2015
BIND Therapeutics Appoints Jonathan Yingling, Ph.D., as Chief Scientific Officer
Biopharmaceuticals Personnel

HSMN NewsFeed - 15 Oct 2014
Navidea Announces Rick Gonzalez as New Chief Executive Officer
Biopharmaceuticals Diagnostics Personnel

HSMN NewsFeed - 26 Sep 2014
Navidea’s Lymphoseek(R) Recommended by CHMP for European Approval in Sentinel Lymph Node Detection for Melanoma, Breast and Certain Head and Neck Cancers
Biopharmaceuticals Oncology Regulatory

HSMN NewsFeed - 3 Sep 2014
BIND Therapeutics Appoints Two New Board Members
Biopharmaceuticals Oncology Personnel

HSMN NewsFeed - 11 Jun 2014
Navidea Biopharmaceuticals’ Lymphoseek(R) (technetium Tc 99m tilmanocept) Injection Demonstrates Preferential Accumulation in Tumor-Positive Sentinel Lymph Nodes in Post-Hoc Analysis
Biopharmaceuticals Oncology

HSMN NewsFeed - 7 Jan 2014
Navidea Biopharmaceuticals Expands Lymphoseek(R) Global Commercialization Efforts
Biopharmaceuticals Radiology Distribution

HSMN NewsFeed - 10 Dec 2013
FDA Grants Fast Track Designation to Navidea Biopharmaceuticals’ Lymphoseek(R) for Sentinel Lymph Node Detection in Patients with Head and Neck Cancer
Diagnostics Oncology FDA

HSMN NewsFeed - 21 Mar 2013
Results of Lymphoseek(R) Phase 3 Clinical Trials in Breast Cancer Published in Annals of Surgical Oncology
Biopharmaceuticals Oncology

HSMN NewsFeed - 5 Jan 2012
Neoprobe Corporation Becomes Navidea Biopharmaceuticals
Biopharmaceuticals

HSMN NewsFeed - 8 Dec 2011
Neoprobe Corporation to Change Company Name to Navidea Biopharmaceuticals
Biopharmaceuticals Diagnostics

Return to NewsFeed

FindReps - Find Great Medical Independent Sales Reps without recruiter fees.

FindReps - available on the Apple App Store for iPhone and iPad.